http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI#head http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI#assertion http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI#provenance http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI#publicationInfo http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI#assertion http://bio2rdf.org/drugbank:DB00262 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00262_DB01097 http://bio2rdf.org/drugbank:DB01097 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00262_DB01097 http://bio2rdf.org/drugbank_resource:DB00262_DB01097 http://purl.org/dc/terms/identifier drugbank_resource:DB00262_DB01097 http://bio2rdf.org/drugbank_resource:DB00262_DB01097 http://purl.org/dc/terms/title DDI between Carmustine and Leflunomide - Immunosuppressants such as carmustine may enhance the adverse/toxic effect of leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased. Consider eliminating the use of a leflunomide loading dose in patients who are receiving other immunosuppressants in order to reduce the risk for serious adverse events such as hematologic toxicity. Also, patients receiving both leflunomide and another immunosuppressive medication should be monitored for bone marrow suppression at least monthly throughout the duration of concurrent therapy. http://bio2rdf.org/drugbank_resource:DB00262_DB01097 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00262_DB01097 http://www.w3.org/2000/01/rdf-schema#label DDI between Carmustine and Leflunomide - Immunosuppressants such as carmustine may enhance the adverse/toxic effect of leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased. Consider eliminating the use of a leflunomide loading dose in patients who are receiving other immunosuppressants in order to reduce the risk for serious adverse events such as hematologic toxicity. Also, patients receiving both leflunomide and another immunosuppressive medication should be monitored for bone marrow suppression at least monthly throughout the duration of concurrent therapy. [drugbank_resource:DB00262_DB01097] http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI#provenance http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI#publicationInfo http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI#signature.MC0CFQCOHVTIXLo2 http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI#signature.MC0CFQCOHVTIXLo2 http://purl.org/nanopub/x/hasSignature MC0CFQCOHVTIXLo2YyBXWyMMCV6oXsUK9gIUILBPmWuE+LnGpKCIRe+RnsU1HIc= http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI#signature.MC0CFQCOHVTIXLo2 http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI http://purl.org/dc/terms/created 2018-03-30T11:12:19.153+02:00 http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI#signature.MC0CFQCOHVTIXLo2 http://bio2rdf.org/drugbank_resource:DB00262_DB01097_nanopub.RA7nBZcwoLarzeQ-MvDK3Z8OgXi-j4uS_GEqVGA5aETBI http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234